Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *central nervous system membrane lipid composition* refers to the diverse mixture of lipid species that make up the membranes of neurons and glial cells in the CNS. Key lipid classes include cholesterol, glycerophospholipids (such as phosphatidylcholine and phosphatidylethanolamine), sphingolipids, and others[3][2][4]. These lipids are essential for cell membrane structure, synaptic function, myelination, and signal transduction[3][5]. The lipid composition varies among different CNS cell types and regions, influencing neuronal function, myelin integrity, and disease susceptibility[4]. Dysregulation or alteration of CNS lipid composition is implicated in a range of neurological diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and brain tumors[2][3][1]. While specific enzymes and metabolic pathways that regulate neuronal lipid synthesis (e.g., c-Fos-mediated activation) may present therapeutic targets, "central nervous system membrane lipid composition" itself is not considered a druggable molecular target but rather a complex characteristic of CNS biology[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system membrane lipid composition.